Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03077087
Other study ID # A16-734
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date April 10, 2017
Est. completion date July 24, 2019

Study information

Verified date September 2019
Source HealthPartners Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, descriptive, pilot case series involving patients with significant burns who are candidates for reconstruction with Integra®. Subjects would have a small area of the wound would, at the time of excision, have the smallest sheet of thin Integra® (125 cm2) placed and be immediately autografted with a 3:1 meshed split-thickness skin graft. Of note, 125 cm2 represents approximately 0.7% of an average sized patient's total body surface area, so for even the smallest burns in our proposed trial, this area would represent a small portion of the patient's area of injury. The remaining injury areas would be covered with standard-thickness Integra® only.


Description:

Integra®, a synthetic dermal substitute, has been utilized in burn care for decades. Typically, 10-14 days after Integra® placement, a patient returns to the operating room, the top silastic layer of the Integra® is removed, and an autograft - a split-thickness skin graft harvested from the patient - is applied directly on top of the incorporated Integra®. The result is regarded to be a cosmetically and functionally superior result to that which would have been obtained had the wound bed itself been autografted at the time of excision, as opposed to being covered by Integra® and autografted during a second operation. Integra® use in single-stage procedures to cover defects without grafting has shown benefit when defects are fairly small, e.g. fingertip injuries, and small head and neck skin cancer resections. While single-stage reconstruction with Integra® has been demonstrated with standard thickness Integra®, this decreased thickness would increase the likelihood of graft survival due to the decreased distance of nutrient diffusion.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date July 24, 2019
Est. primary completion date July 24, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 125 Years
Eligibility Inclusion Criteria: - English-speaking adult burn patients greater than 18 years old, admitted with burn injuries eligible for Integra® reconstruction at the discretion of the burn attending physicians. Exclusion Criteria: - patients with isolated hand or face burns - these burns are treated with sheet grafts (unmeshed); the 3:1 mesh grafts would not be used on these cosmetically sensitive areas. If they have hand and/or face burns in addition to other areas, they will not be excluded. However, the study itself will not be performed on the hands or face. Additionally, patients unable to present to our clinic for routine follow-up due to geographic limitations or otherwise will be ineligible.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
thin Integra® (125 cm2)
125 cm2 represents approximately 0.7% of an average sized patient's total body surface area. The remaining injury areas would be covered with standard-thickness Integra® only. The donor graft, a 4 cm x 10 cm sheet of skin, would be meshed in a 3:1 ratio to be expanded to cover the 125 cm2 sheet of thin Integra®. The patient's post-operative care would be largely unchanged, although the patient would have a donor site of 40 cm2 that would be dressed and managed in the usual fashion.

Locations

Country Name City State
United States Regions Hospital Saint Paul Minnesota

Sponsors (1)

Lead Sponsor Collaborator
HealthPartners Institute

Country where clinical trial is conducted

United States, 

References & Publications (9)

Branski LK, Herndon DN, Pereira C, Mlcak RP, Celis MM, Lee JO, Sanford AP, Norbury WB, Zhang XJ, Jeschke MG. Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med. 2007 Nov;35(11):2615-23. doi: 10.1097/01.CCM.0000285991.36698.E2. — View Citation

Burd A, Wong PS. One-stage Integra reconstruction in head and neck defects. J Plast Reconstr Aesthet Surg. 2010 Mar;63(3):404-9. doi: 10.1016/j.bjps.2008.11.105. Epub 2009 Feb 28. — View Citation

De Angelis B, Gentile P, Tati E, Bottini DJ, Bocchini I, Orlandi F, Pepe G, Di Segni C, Cervelli G, Cervelli V. One-Stage Reconstruction of Scalp after Full-Thickness Oncologic Defects Using a Dermal Regeneration Template (Integra). Biomed Res Int. 2015;2015:698385. doi: 10.1155/2015/698385. Epub 2015 Nov 16. — View Citation

Demiri E, Papaconstantinou A, Dionyssiou D, Dionyssopoulos A, Kaidoglou K, Efstratiou I. Reconstruction of skin avulsion injuries of the upper extremity with integra((R)) dermal regeneration template and skin grafts in a single-stage procedure. Arch Orthop Trauma Surg. 2013 Nov;133(11):1521-6. doi: 10.1007/s00402-013-1834-2. Epub 2013 Aug 21. — View Citation

Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J, Jordan M, McManus W, Solem L, Warden G, et al. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg. 1988 Sep;208(3):313-20. doi: 10.1097/00000658-198809000-00008. — View Citation

Jacoby SM, Bachoura A, Chen NC, Shin EK, Katolik LI. One-stage Integra coverage for fingertip injuries. Hand (N Y). 2013 Sep;8(3):291-5. doi: 10.1007/s11552-013-9513-x. — View Citation

Kosutic D, Beasung E, Dempsey M, Ryan L, Fauzi Z, O'Sullyvan B, Orr D. Single-layer Integra for one-stage reconstruction of scalp defects with exposed bone following full-thickness burn injury: a novel technique. Burns. 2012 Feb;38(1):143-5. doi: 10.1016/j.burns.2011.08.019. Epub 2011 Nov 1. No abstract available. — View Citation

Nguyen DQ, Potokar TS, Price P. An objective long-term evaluation of Integra (a dermal skin substitute) and split thickness skin grafts, in acute burns and reconstructive surgery. Burns. 2010 Feb;36(1):23-8. doi: 10.1016/j.burns.2009.07.011. Epub 2009 Oct 27. — View Citation

Ryan CM, Schoenfeld DA, Malloy M, Schulz JT 3rd, Sheridan RL, Tompkins RG. Use of Integra artificial skin is associated with decreased length of stay for severely injured adult burn survivors. J Burn Care Rehabil. 2002 Sep-Oct;23(5):311-7. doi: 10.1097/00004630-200209000-00002. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The Time to 95% Healing of the Single-stage Reconstructed Skin Graft 95% healing determined as charted in Standard of Care follow up visits Up to 12 months
Secondary Frequency of Complications: Infection, Seroma, Hematoma, Sloughing, and Graft Loss Compared to the same characteristics of the adjacent (control) 125 cm2 skin graft Up to 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04368117 - STAT: Standard Therapy Plus Active Therapy N/A
Recruiting NCT06223269 - Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting Phase 3
Completed NCT05167461 - AutoMated BUrn Diagnostic System for Healthcare (AMBUSH)
Terminated NCT03148977 - Evaluating MMPs in Burns
Completed NCT02362386 - Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System N/A
Completed NCT04073030 - Burn Injury In a Child Due to Cyanoacrylate-Based Nail Glue- Case Report and Literature Review
Recruiting NCT04138394 - VItamin C in Thermal injuRY: The VICToRY Trial Phase 3
Withdrawn NCT03248154 - Biofilm Infection in Adults and Children Burn Injury N/A
Recruiting NCT05084183 - Evaluation of the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag® N/A
Completed NCT04500314 - Efficacy of Whole-body Vibration on Balance Control, Postural Stability and Mobility After Thermal Burn Injuries. N/A
Withdrawn NCT04684121 - Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing Phase 2
Suspended NCT03435172 - Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds N/A
Available NCT04040660 - Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries